Table 3. Mortality with AF after ACS.

HR=Hazard Ratio, OR=Odds Ratio, RR=Relative Risk, N/A=Data Not Available, NSTEMI=Non ST-Segment Elevation Myocardial Infraction

Author/Study	Publication Date	In-hopital Mortality	Follow-up	Risk of Death	Follow-up	Risk of Death
Jabre	2011	N/A	6.6 year	HR 3.77(3.37-4.21)	N/A	N/A
Lau/ACACIA	2009	OR 2.2(1.0-4.6)	1 year	HR 1.36(0.84-2.20)	N/A	N/A
Berton	2009	OR 1.9(0.8 to 4.6)	N/A	N/A	7 years	OR 1.6(1.2-2.3)
Lopes	2008	N/A	7 day	NSTEMI HR 2.30(1.83-2.90), STEMI HR 1.65(1.44-	1 year	NSTEMI HR 1.67(1.41-1.99), STEMI HR 2.37(1.79-
Siu	2007	N/A	2 year	Not Significant	N/A	N/A
Kober/VALIANT	2006	N/A	3 year	HR 1.32(1.20-1.45)	N/A	N/A
Lehto/OPTIMAAL	2005	N/A	30 day	HR 3.83(1.97-7.43)	3 years	HR 1.82(1.39-2.39)
Kinjo/OACIS	2003	HR 1.42(0.88-2.31)	1 year	HR 3.04(1.24-7.48)	N/A	N/A
Mehta/GRACE	2003	OR 1.65(1.30-2.09)	N/A	N/A	N/A	N/A
Goldberg	2002	OR 1.38(0.98-1.94)	5 year	HR 1.23(0.99-1.52)	N/A	N/A
Al-Khatib/PURSUIT	2001	N/A	30 day	HR 4.4(3.3-5.8)	6 months	HR 3.0(2.4-3.8
Pizetti/GISSI-III	2001	RR 1.98(1.67-2.34)	6 months	OR 1.42(0.88-2.31)	4 years	RR 1.78(1.60-1.99)
Rathore/CCP	2000	OR 1.35(1.28-1.42	30 day	OR 1.31(1.25-1.37)	1 year	OR 1.51(1.44-1.58)
Wong(17)/GUSTO-III	2000	N/A	30 day	OR 1.49(1.17-1.89)	1 year	OR 1.64(1.35-2.01)
Pedersen(33)/TRACE	1999	OR 1.5(1.2-1.9)	5 year	OR 1.3(1.2-1.4)	N/A	N/A
Eldar	1998	N/A	30 day	OR 1.32(0.92-1.87)	1 year	RR 1.33(1.05-1.87)
Crenshaw/GUSTO-I	1997	13.8% AF vs 5.9% no AF	30 day	OR 1.5(1.2-1.9)	N/A	N/A
Sakata	1997	40% AF vs 14% no AF	8 year	OR3.05(1.85-5.00)	N/A	N/A
Madias	1996	Not Significant	N/A	N/A	N/A	N/A